The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ISOFTSTONE HOLDINGS LTD-ADS | ADR | 46489B108 | 684 | 132,500 | SH | SOLE | none | 132,500 | 0 | 0 | |
| LE GAGA HOLDINGS LTD-ADR | ADR | 521168104 | 528 | 142,950 | SH | SOLE | none | 142,950 | 0 | 0 | |
| SIMCERE PHARMACEUTICAL-ADR | ADR | 82859P104 | 2,411 | 254,299 | SH | SOLE | none | 254,299 | 0 | 0 | |
| YONGYE INTERNATIONAL INC | COM | 98607B106 | 5,437 | 1,016,095 | SH | SOLE | none | 1,016,095 | 0 | 0 | |